Physician profile
Mark D Esarey
NPI 1548267099
$1,559.05
in general payments reported to CMS, 2019-2025
18 companies · $194 in 2025
The $194 reported for 2025 was less than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $208 · 2020: $43.83 · 2021: $119 · 2022: $326 · 2023: $235 · 2024: $433 · 2025: $194.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $848 · Entertainment: $14.25.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $847.60 |
| Entertainment | $14.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $532.48 | 2019-2025 | Total30, Precision7, Precision 1 |
| Sun Pharmaceutical Industries INC. | $155.34 | 2020-2023 | Cequa |
| Bausch & Lomb Americas INC. | $137.86 | 2024-2025 | Miebo, Xiidra, Biotrue |
| Dompe US, INC. | $101.78 | 2024 | Oxervate |
| Abb Con-Cise Optical Group LLC | $97.15 | 2019-2023 | Contact Lens, Spectacle Lenses |
| Coopervision INC. | $87.04 | 2019-2024 | Myday Contact Lens |
| Allergan, INC. | $85.59 | 2019 | |
| Biotissue Holdings INC. | $83.34 | 2021 | |
| Sight Sciences, INC. | $46.07 | 2020-2023 | Tearcare System |
| Horizon Therapeutics Plc | $46.01 | 2023 | Tepezza |
| Abbvie INC. | $34.12 | 2022 | |
| Mallinckrodt Hospital Products INC. | $31.21 | 2024 | Acthar |
| Novartis Pharmaceuticals Corporation | $30.00 | 2021-2023 | |
| Optos, INC. | $25.97 | 2021-2024 | Oct Ophthalmoscope, Panoramic Ophthalmoscope, Nfc-700 |
| Shire North American Group INC | $23.18 | 2019 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Maculogix, INC. | $17.44 | 2019-2020 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $12.72 | 2019 | |
| Oyster Point Pharma, INC. | $11.75 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Esarey listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.